However, compounded semaglutide products have raised safety concerns, with the FDA reporting dosing errors leading to hospitalizations (Lexology, March 18, 2025), underscoring the need for rigorous regulatory oversight
Is the heart rate increase from GLP-1 dangerous
Clinically shown to reduce body weight and body fat without losing muscle mass 9x More weight loss than will power alone 6.5x More reduction in body fat vs placebo 3.5x Reduction in visceral fat vs placebo 30% Reduction in hunger after an hour 40% Reduction in cravings after an hour 18% Reduction in calories consumed after an hour No loss of muscle mass with weight loss Calocurb & GLP-1: How does it work
They also reduce glucagon secretion, which prevents the liver from producing excess glucose
Many find 4mg or 8mg effective Consider microdosing if GI side effects are limiting your progress Use a calculator to visualize your protocol and track steady state References Jastreboff AM, Kaplan LM, Fras JP, et al
DPP-4 inhibitors: Linagliptin: hepatobiliary excretion (no dose adjustment required in patients with renal impairment, making it preferred) Other DPP-4 inhibitors (sitagliptin, vildagliptin, saxagliptin, and alogliptin) are predominantly eliminated by the kidneys, so dosage must be adjusted in cases of severe renal dysfunction
